These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 12795776)

  • 1. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    Bowden CR; Marchione CS
    J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise tolerance with nebivolol and atenolol.
    Van Bortel LM; van Baak MA
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.
    Van Nueten L; De Crée J
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):339-44. PubMed ID: 9825177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of nebivolol in man.
    Van Bortel LM; de Hoon JN; Kool MJ; Wijnen JA; Vertommen CI; Van Nueten LG
    Eur J Clin Pharmacol; 1997; 51(5):379-84. PubMed ID: 9049578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A; Feely J
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metabolic assessment of the beta 1 selectivity of bisoprolol.
    Haffner CA; Horton RC; Lewis HM; Hughes B; Kendall MJ
    J Hum Hypertens; 1992 Oct; 6(5):397-400. PubMed ID: 1361206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of atenolol and nebivolol in isolated systolic hypertension.
    Dhakam Z; Yasmin ; McEniery CM; Burton T; Brown MJ; Wilkinson IB
    J Hypertens; 2008 Feb; 26(2):351-6. PubMed ID: 18192850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of beta-1 selectivity of bisoprolol and atenolol by means of their influence on the lipolytic response to an infusion of terbutaline.
    Kendall MJ; Akhlaghi S; Haffner CA
    J Clin Pharm Ther; 1991 Feb; 16(1):25-9. PubMed ID: 1673971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
    Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is metoprolol CR/ZOK more selective than conventional metoprolol and atenolol?
    Kendall M; Akhlaghi S; Hughes B; Lewis H
    J Clin Pharmacol; 1990 Feb; 30(S2):S98-102. PubMed ID: 2155948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
    De Crée J; Cobo C; Geukens H; Verhaegen H
    Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebivolol: endothelium-mediated vasodilating effect.
    Ritter JM
    J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
    Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol increases arterial distensibility in vivo.
    McEniery CM; Schmitt M; Qasem A; Webb DJ; Avolio AP; Wilkinson IB; Cockcroft JR
    Hypertension; 2004 Sep; 44(3):305-10. PubMed ID: 15262912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade.
    Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF
    J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.